CCR4 and COVID-19: Recently, Xu et al. reported increased numbers of peripheral CCR4+CCR6+ Th17 cells in a 50-year-old male patient with COVID-19 [65], suggesting the possible presence of SARS-CoV-2-induced inflammatory damage to the patient's tissues.